Biomarcadores moleculares: una nueva herramienta en el diagnóstico de la preeclampsia

F. Hernández Restrepo, N. Perilla Hernández, L. M. Martínez Sánchez, C. Ruiz Mejía

    Resultado de la investigación: Contribución a una revistaEstudio breverevisión exhaustiva


    Pre-eclampsia is a common complication during pregnancy that is associated with high rates of maternal and foetal morbidity and mortality, so a timely diagnosis and active surveillance are essential in the management of this condition. Obstetrical gynaecological history is currently the only tool available to stratify the risk of developing this condition. However, this is not sufficient, given the complex and still unknown pathophysiology of pre-eclampsia. Molecular biomarkers have emerged as a possible screening tool for this disorder, showing great potential in current studies. However, the clinical usefulness of these molecules has not yet been determined, and a specific biomarker has not been standardised to predict the development of the disease. It is therefore necessary to carry out larger and more complex studies to determine the true clinical utility of these molecules.

    Título traducido de la contribuciónMolecular biomarkers: A new tool for the diagnosis of pre-eclampsia
    Idioma originalEspañol
    Páginas (desde-hasta)66-72
    Número de páginas7
    PublicaciónClinica e Investigacion en Ginecologia y Obstetricia
    EstadoPublicada - 1 abr. 2017

    Nota bibliográfica

    Publisher Copyright:
    © 2016 Elsevier España, S.L.U.

    Palabras clave

    • Biological markers
    • Diagnosis
    • Physiopathology
    • Pre-eclampsia


    Profundice en los temas de investigación de 'Biomarcadores moleculares: una nueva herramienta en el diagnóstico de la preeclampsia'. En conjunto forman una huella única.

    Citar esto